Lilly Endowment Sells $48M in Eli Lilly (LLY) Stock
ELI LILLY & Co
Subscribe to track LLY
Premium users can add ticker alerts and receive realtime notification updates.
Filing Summary
Lilly Endowment Sells $48M in Eli Lilly (LLY) Stock
Company: ELI LILLY & Co (LLY) Form: 4 | Filed: 2025-11-14 Significance: Low
Insider: LILLY ENDOWMENT INC Relationship: 10% Owner
Transaction: • Type: Sale • Shares: 46,606 • Avg. Price: $1030.27 • Value: $48,016,892 • Owned After: 93,060,372
Key Insight: While the dollar value is large, this sale represents a minuscule fraction (<0.01%) of the company's market cap and a tiny portion (<0.05%) of the Endowment's total holdings in LLY.
This is PUBLIC SEC data for educational purposes. Not investment advice.
Comprehensive Analysis
SEC Filing Analysis: ELI LILLY & Co (LLY)
Executive Summary
- Trading Significance: Low
- Key Takeaway: Lilly Endowment Inc., a major 10% owner, executed a $48 million sale of Eli Lilly stock, which is immaterial relative to the company's massive market capitalization and the Endowment's vast holdings.
- Market Impact: The transaction is considered routine portfolio management and is unlikely to have a material impact on the stock price.
Company Information
| Field | Value |
|---|---|
| Company | ELI LILLY & Co |
| Ticker Symbol | LLY |
| CIK | 0000059478 |
| Industry | PHARMACEUTICAL PREPARATIONS |
Insider Information
| Field | Value |
|---|---|
| Name | LILLY ENDOWMENT INC |
| CIK | 0000316011 |
| Title/Position | null |
| Relationship | 10% Owner |
Transaction Details
| Field | Value |
|---|---|
| Form Type | 4 |
| Transaction Date | 2025-11-13 |
| Transaction Code | S (Sale) |
| Security Type | Common Stock |
| Shares Involved | 46,606 |
| Price Per Share | $1030.27 (Weighted Avg.) |
| Total Value | $48,016,892 |
| Shares Owned After | 93,060,372 |
| Ownership Type | Direct |
Financial Impact Assessment
Transaction Materiality
| Metric | Value |
|---|---|
| Transaction Value | $48,016,892 |
| % of Market Cap | 0.0053% |
| Shares Transacted | 46,606 |
| % of Shares Outstanding | 0.0049% |
| Post-Transaction Ownership | 93,060,372 shares (9.83% of outstanding) |
| Materiality Assessment | Low |
Impact Evaluation
- Market Cap Context: For a mega-cap company valued at over $910 billion, a $48 million transaction is negligible, representing just 0.0053% of its market value.
- Ownership Concentration: The Lilly Endowment remains a cornerstone investor, holding approximately 9.83% of all outstanding shares after the sale. This transaction represents a sale of only 0.05% of its prior holdings, indicating no significant change in its investment thesis.
- Transaction Significance: The sale is classified as having low significance. The small percentages relative to market cap, shares outstanding, and the insider's own holdings suggest this is likely part of a planned, regular divestment for operational or diversification purposes rather than a reaction to company-specific news.
Additional Context
Transaction Notes
- Special Circumstances: The sale was executed in multiple transactions at weighted average prices, as detailed in the filing's footnotes. This is a common practice for large block trades to minimize market impact.
Get Real-Time Alerts
Join our community to receive instant notifications when high-significance filings are published
Important Disclaimer
This content is drawn from public SEC filings and may contain errors. It is for informational purposes only and is not investment, legal, or tax advice.
Nothing here is a recommendation to buy, sell, or hold any security. Do your own due diligence.
